Intellectual Property India Publishes Patent Application for 'Natural Killer (NK) Cell Engagers Binding To NKP46 And BCMA Variants With FC-Engineering' Filed by Sanofi; and Innate Pharma

MUMBAI, India, Feb. 21 -- Intellectual Property India has published a patent application (202417101485 A) filed by Sanofi; and Innate Pharma, Paris, on Dec. 20, 2024, for 'natural killer (nk) cell engagers binding to nkp46 and bcma variants with fc-engineering.'

Inventor(s) include Gourdin, Nicolas; Gauthier, Laurent; Tang, Alexandre; Chiron, Marielle; Virone-Oddos, Angela; Masiero, Alessandro; Beninga, Jochen; Focken, Ingo; Tillmann, Bodo; Lange, Christian; Rao, Sambasiva; Zhou, Yanfeng; and Sevigny, Leila.

The application for the patent was published on Feb. 21, under issue no. 08/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure relates to multifunctional binding proteins comprising a...